(Q44031590)

English

Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Piotr Rutkowski

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Agnieszka Wozniak

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Janusz A Siedlecki

object named as

Janusz A Siedlecki

10

0 references

9

object named as

Janusz Limon

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Maria Debiec-Rychter

3

object named as

Maria Dębiec-Rychter

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Konrad Ptaszyński

7

object named as

Konrad Ptaszynski

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Monika Jurkowska

8

object named as

Monika Jurkowska

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Wirginiusz Dziewirski

5

object named as

Wirginiusz Dziewirski

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Marcin Zdzienicki

6

object named as

Marcin Zdzienicki

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

author name string

Michał Kąkol

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

language of work or name

0 references

publication date

31 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

117

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

4916-4924

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Gastrointestinal stromal tumor (GIST).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

21 January 2018

Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

21 January 2018

Developments in targeted therapy of advanced gastrointestinal stromal tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

21 January 2018

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

21 January 2018

KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

21 January 2018

Biology of gastrointestinal stromal tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

21 January 2018

KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

21 January 2018

Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

21 January 2018

Implications of mutational analysis for the management of patients with gastrointestinal stromal tumors and the application of targeted therapies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

21 January 2018

Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

21 January 2018

Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

21 January 2018

Clinical management of gastrointestinal stromal tumors: before and after STI-571.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

21 January 2018

Clinical presentation of gastrointestinal stromal tumors and treatment of operable disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

21 January 2018

The effect of surgery and grade on outcome of gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

21 January 2018

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

21 January 2018

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

21 January 2018

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

21 January 2018

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

21 January 2018

Risk stratification of patients diagnosed with gastrointestinal stromal tumor.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

21 January 2018

Gastrointestinal stromal tumors: pathology and prognosis at different sites

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

21 January 2018

Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

21 January 2018

Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

21 January 2018

Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

21 January 2018

Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

21 January 2018

A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

21 January 2018

Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

21 January 2018

Malignant gastrointestinal stromal tumors of the small intestine: a review of 50 cases from a prospective database.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

21 January 2018

Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

21 January 2018

Outcome of Metastatic GIST in the Era before Tyrosine Kinase Inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

21 January 2018

Prognostic factors after surgery of primary resectable gastrointestinal stromal tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnosis of gastrointestinal stromal tumors: A consensus approach

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk Criteria and Prognostic Factors for Predicting Recurrences After Resection of Primary Gastrointestinal Stromal Tumor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

7 January 2021

based on heuristic

inferred from DOI database lookup

NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgical outcomes of gastrointestinal sarcoma including gastrointestinal stromal tumors: a population-based examination

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26079

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.26079

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44031590&oldid=2137717478"